Join the session using the link: Zoom Link

Objectives

After participating in this educational activity, attendees should be able to:

1| Describe expanded access pathway categories for drugs and biologics as well as devices.

2| Define immediately life-threatening disease or condition.

3| Differentiate between expanded access and compassionate use.

4| Describe the process of initiating a request for expanded access to a drug or biologic/device.

Presenter(s): 
Susan Garrow-Sloan, RN, CCRP
Education and Quality Assurance (EQA) Specialist
Baystate Health
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Susan Garrow-Sloan, RN, CCRP, Education and Quality Assurance (EQA) Specialist, Baystate HealthSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
09/16/2026 - 2:00pm to 3:00pm EDT
Location: 
Webinar/Zoom
MA
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Risk Management
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.